Medifast Inc (MED) stock
MEDNYSEMiscellaneous Food Preparations & Kindred ProductsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 26, 2026Score 10/3067% below fair value
$11.75−0.23 (-1.92%)
Close on Nov 20, 2026Market cap $131.40MP/E –Yield 0.00%
Medifast free cash flow
Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.
Medifast's free cash flow for the twelve months ending Sep 30, 2026 was -$3.87M, down 698.9% year over year. For fiscal 2025 it was $1.25M, down 92.7% from the year before. Over ten years it grew -26.3% a year on average. The highest annual figure on record is $177.89M in fiscal 2022.
Annual free cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.25M | -92.7% |
| FY2024 | Dec 31, 2024 | $17.02M | -87.9% |
| FY2023 | Dec 31, 2023 | $141.17M | -20.6% |
| FY2022 | Dec 31, 2022 | $177.89M | +194.8% |
| FY2021 | Dec 31, 2021 | $60.34M | -56.7% |
| FY2020 | Dec 31, 2020 | $139.31M | +87.7% |
| FY2019 | Dec 31, 2019 | $74.20M | +32.8% |
| FY2018 | Dec 31, 2018 | $55.88M | +39.7% |
| FY2017 | Dec 31, 2017 | $40.00M | +78.0% |
| FY2016 | Dec 31, 2016 | $22.47M | -15.5% |
| FY2015 | Dec 31, 2015 | $26.59M | +43.6% |
| FY2014 | Dec 31, 2014 | $18.51M | -40.2% |
| FY2013 | Dec 31, 2013 | $30.97M | -3.6% |
| FY2012 | Dec 31, 2012 | $32.14M | +56.0% |
| FY2011 | Dec 31, 2011 | $20.60M | +23.2% |
| FY2010 | Dec 31, 2010 | $16.71M | +19.1% |
| FY2009 | Dec 31, 2009 | $14.04M | – |
Quarterly free cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $2.87M | -73.3% |
| Q2 FY2026 | Jun 30, 2026 | $728.00K | – |
| Q1 FY2026 | Mar 31, 2026 | -$836.00K | -144.4% |
| Q4 FY2025 | Dec 31, 2025 | -$6.63M | – |
| Q3 FY2025 | Sep 30, 2025 | $10.75M | +39.9% |
| Q2 FY2025 | Jun 30, 2025 | -$4.76M | -142.7% |
| Q1 FY2025 | Mar 31, 2025 | $1.88M | -65.4% |
| Q4 FY2024 | Dec 31, 2024 | -$7.23M | -175.5% |
| Q3 FY2024 | Sep 30, 2024 | $7.68M | -72.8% |
| Q2 FY2024 | Jun 30, 2024 | $11.13M | -73.1% |
| Q1 FY2024 | Mar 31, 2024 | $5.44M | -91.2% |
| Q4 FY2023 | Dec 31, 2023 | $9.58M | -77.6% |
| Q3 FY2023 | Sep 30, 2023 | $28.25M | -47.3% |
| Q2 FY2023 | Jun 30, 2023 | $41.40M | +1.2% |
| Q1 FY2023 | Mar 31, 2023 | $61.94M | +52.3% |
| Q4 FY2022 | Dec 31, 2022 | $42.68M | – |
| Q3 FY2022 | Sep 30, 2022 | $53.63M | +891.1% |
| Q2 FY2022 | Jun 30, 2022 | $40.92M | +208.1% |
| Q1 FY2022 | Mar 31, 2022 | $40.66M | -33.0% |
| Q4 FY2021 | Dec 31, 2021 | -$19.08M | -207.2% |
| Q3 FY2021 | Sep 30, 2021 | $5.41M | -85.7% |
| Q2 FY2021 | Jun 30, 2021 | $13.28M | -76.8% |
| Q1 FY2021 | Mar 31, 2021 | $60.73M | +129.7% |
| Q4 FY2020 | Dec 31, 2020 | $17.79M | -2.9% |
| Q3 FY2020 | Sep 30, 2020 | $37.85M | +141.9% |
| Q2 FY2020 | Jun 30, 2020 | $57.23M | +378.9% |
| Q1 FY2020 | Mar 31, 2020 | $26.44M | -6.5% |
| Q4 FY2019 | Dec 31, 2019 | $18.32M | +34.3% |
| Q3 FY2019 | Sep 30, 2019 | $15.65M | +170.0% |
| Q2 FY2019 | Jun 30, 2019 | $11.95M | -39.4% |
| Q1 FY2019 | Mar 31, 2019 | $28.29M | +69.2% |
| Q4 FY2018 | Dec 31, 2018 | $13.64M | +49.6% |
| Q3 FY2018 | Sep 30, 2018 | $5.80M | -48.0% |
| Q2 FY2018 | Jun 30, 2018 | $19.72M | +45.9% |
| Q1 FY2018 | Mar 31, 2018 | $16.72M | +169.1% |
| Q4 FY2017 | Dec 31, 2017 | $9.12M | – |
| Q3 FY2017 | Sep 30, 2017 | $11.15M | – |
| Q2 FY2017 | Jun 30, 2017 | $13.52M | – |
| Q1 FY2017 | Mar 31, 2017 | $6.21M | – |
| Q4 FY2016 | Dec 31, 2016 | -$1.15M | – |
See a number that looks wrong?